Hepatitis Australia, incorporated in 1997, is the peak community organisation to progress national action on issues of importance to people affected by hepatitis B and hepatitis C. Our members are the eight state and territory hepatitis organisations.
An end to hepatitis B and hepatitis C in Australia.
To lead an effective national community response to hepatitis B and hepatitis C in Australia.
Our members are the eight state and territory hepatitis organisations:
Northern Territory AIDS and Hepatitis Council, and
Tasmanian Council on AIDS, Hepatitis and Related Diseases.
The way we work:
We respect Aboriginal and Torres Strait Islander cultures, traditions, views and ways of life.
We value cultural diversity and promote equality.
We uphold harm reduction principles.
We promote the empowerment of hepatitis B and hepatitis C communities.
We utilise evidence to inform our policies and activities.
We are ethical, accountable, committed and professional.
The people we work for:
Hepatitis Australia works to improve health and social outcomes for all Australians who are at risk of, or living with hepatitis B or hepatitis C.
We pay particular attention to those groups which are at higher risk of infection or have a disproportionate burden of chronic disease.
Our Strategic Plan 2016 - 2019
You can download a copy of our Strategic Plan by clicking here or on the image below.
Hepatitis Australia Annual Report 2017 - 2018 - Download a copy
“Prior to the PBS listing of the direct-acting antivirals the number of people progressing to liver cancer or dying as a consequence of their hepatitis C infection was rising each year. Since then the tide has turned due to the high uptake of treatment among those with hepatitis C related cirrhosis. For the first time in many years we have seen small decreases in new cases of liver cancer and hepatitis C-related deaths.” Extract from Presidents Message (p14)
Hepatitis Australia Annual Report 2016-2017 - Download a copy
"Elimination is the word that has been on everyone’s lips this year and there are undoubtedly unprecedented opportunities to act decisively to end the hepatitis B and hepatitis C epidemics in Australia by 2030, in line with the World Health Organization’s global targets." CEO and President's Message (p11)
Annual Report 2015-2016 - Download a copy
"During 2015 to 2016 much of our work was associated with advocacy for universal access to the new hepatitis C medications, as well as preparing for the changes to treatment and responding to system issues arising during the first few months of the rollout." - Highlights from 2015-2016 (p12)
Page updated: 23 November 2018